[THE RESULTS OF THE ANALYSIS OF RISK FACTORS, CARDIOVASCULAR RISK, CHRONIC NON-COMMUNICABLE DISEASES IN YOUNG AND MIDDLE-AGED PATIENTS, DEPENDING ON THE EDUCATION].

Aim: To assess the frequency of risk factors (RF), total cardiovascular risk (CHR) and their association with the level of education in young and middle-aged people.

Methods: Persons aged 25-59 (40.4 ± 9.

[Gut microbiota is a factor of risk for obesity and type 2 diabetes].

Gut microbiota (GM) is a set of bacteria which colonize the gastrointestinal tract. GM and its active metabolites take part in intestinal and hepatic gluconeogenesis, in the synthesis of incretin hormones, and affect the regulation of appetite. Thus, GM and its metabolites participate in the homeostasis of carbohydrates and fats.

[C-peptide and its role as a predicator of the cardiovascular complications].

C-peptide is secreted from proinsulin and over the recent decade is considered as an active peptide that leads to different capillary actions and macrovascular complications in patients with type 2 diabetes mellitus. Results of the recent researches showed the C-peptide uptake in the blood vessel walls, in the juxtaglomerular apparatus of malpighian tuft, induction of local inflammation, proliferative effect on mesangial cell. The given effects showed an atherogenic role of C-peptide.

[Modern approaches to the problem of comprehensive training of patients with ischemic heart disease combined with type 2 diabetes mellitus which undergo interventional coronary intervention (literature review)].

On the basis of 42 analyzed sources of literature was performed a study about the problem of comprehensive training of patients with ischemic heart disease combined with type 2 diabetes mellitus which undergo interventional coronary intervention. It was noted that disease management programs for patients with associated pathology and comprehensive training of patients with ischemic heart disease combined with type 2 diabetes mellitus, which undergo interventional coronary intervention, are not developed. Therefore, in recent decades there emerged a need for comprehensive training of patients with associated pathology development of relevant structured programs of training, estimation of near and late results of training.

[Specific features of hypolipidemic therapy in patients with abdominal ischemic disease].

Aim: To evaluate the efficiency and safety of combined drug therapy incorporating Ursofalk (Dr Falk Pharma GmbH, Germany) and a low-dose statin on the clinical course of the disease and blood lipid composition parameters in high-risk patients with abdominal ischemic disease (AID) and hepatic ischemic steatosis resulting from atherosclerotic lesion of the abdominal aorta (AA) and its unpaired visceral branches (UVB).

Subjects And Methods: One hundred and thirty-nine patients (95 (68.3%) men and 44 (31.

[Ischemic visceral syndromes in atherosclerosis of the abdominal aorta].

The authors provide the data on the clinical picture and methods of diagnosis, conservative treatment of ischemic lesions of the alimentary organs in 152 patients suffering from abdominal atherosclerosis. Present a systematized description of the visceral syndromes of the ischemic genesis which can be used in the clinical practice for diagnosing abdominal atherosclerosis and specification of the site of arterial occlusion of the branches of the abdominal aorta.

[Diagnostic aspects of ischemic abdominal visceropathy].

The clinical picture and results of instrumental and laboratory investigation of 60 patients suffering from atherosclerosis of unpaired branches of the abdominal aorta with the involvement of the digestive system (ischemic abdominal visceropathy) were analyzed. A scheme of combined clinico-instrumental diagnosis of abdominal atherosclerosis to be made in a hospital was developed.